Skip to main content

Challenging Patient Cases in Acute Myeloid Leukemia

Module #3 in the series, AML Strategies: Decision-Making at Each Point in Care

This is part 3 of a 3-module series. To access the other modules, click here.

Click Here to Participate 

1.0 CE Credit Available Until: October 31, 2022
Format: Interactive recorded webinar

 

Target Audience

The target audience includes hematology/oncology nurses, physician assistants, nurse practitioners, transplant clinicians, and other members of the multidisciplinary cancer care team who are involved in the diagnosis and management of patients with AML.

Description

This educational activity will provide members of the multidisciplinary cancer care team with the latest information to improve their knowledge and confidence in the diagnosis and treatment of AML through interactive online activities. This module explores two challenging case studies and discusses the management of patients with refractory and relapsed AML and those that may be eligible for transplant.

Learning Objectives:

Upon completion of the activity, participants should be able to do the following:

  • Choose appropriate tests to diagnose AML
  • Review therapeutic options for the management of AML
  • Establish an appropriate sequence of therapies
  • Manage relapsed and refractory AML
  • Identify appropriate patients for transplantation
  • Monitor patients for adverse events associated with treatment and manage accordingly
     

Steering Committee/Faculty:

Jessica Altman, MD (Faculty Advisor and Chair)
Professor of Medicine
Hematology Oncology Division
Feinberg School of Medicine
Robert H. Lurie Comprehensive Cancer Center
Northwestern University
Chicago, IL

Uma Borate, MD, MS
Clinical Associate Professor
Division of Hematology
The Ohio State University Comprehensive Cancer Center
Columbus, OH

Jennie Goble, PA-C
Instructor of Medicine
Division of Hematology
Mayo Clinic 
Rochester, MN
 

Continuing Education

Nurses
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 1.0 continuing education contact hour through the California Board of Registered Nursing.

Nurse Practitioners

AANP

This activity is approved for 1.0 contact hour(s) of continuing education (which includes 0.5 hour(s) of pharmacology) by the American Association of Nurse Practitioners®. Activity ID# 21105211. This activity was planned in accordance with AANP Accreditation Standards and Policies.

Physician Assistants

AANP

This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid from 9/30/2021 to 9/29/2022. PAs should only claim credit commensurate with the extent of their participation. AAPA reference number: CME-203462

ONCC ILNA
The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points.

ONCC review is only for designating content to be used for ILNA points and is not for NCPD accreditation. NCPD programs must be formally approved for contact hours by an acceptable accreditor/approver of nursing NCPD to be used for recertification by ONCC. If the NCPD provider fails to obtain formal approval to award contact hours by an acceptable accrediting/approval body, no information related to ONCC recertification or ILNA categories may be used in relation to the program.

ILNA Categories and Points: Care Continuum 1| Coordination of Care 1| Foundation of Transplant 1| Roles of the APN 1| Symptom Management 1| Treatment 1| Total Maximum = 1 ILNA Points  

Note that the course content applies to multiple subject areas across multiple credentials. The numerical value indicated above is the maximum amount of points that can be claimed in each subject area.  The total amount of points claimed may not exceed the total amount of nursing continuing professional development (NCPD) or CME awarded from this course and may only apply to the credential you are renewing.

Provider statement
This activity is provided by The Leukemia & Lymphoma Society and produced in collaboration with The France Foundation, the American Society of Hematology, and the American Society for Clinical Pathology.

Providers

Supporters

This activity is supported by educational grants from Astellas and Bristol Myers Squibb.

 

Click Here to Participate 

Participants gain access to the webinar via the registration button above.

For questions, concerns, or for assistance for people with disabilities or grievances, please contact us at ProfEducation@LLS.org.



< Back to Continuing Education